No article text was recorded for this version.
allosteric site targeting
Version 1 of 137 papers54 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Identification of new allosteric sites and modulators of AChE through computational and experimental tools
- Blog: Molecular Motions as a Drug Target: Mechanistic Simulations of Anthrax Toxin Edema Factor Function Led to the Discovery of Novel Allosteric Inhibitors
- Blog: Characterization of natural product inhibitors of quorum sensing reveals competitive inhibition of <i>Pseudomonas aeruginosa</i> RhlR by <i>ortho</i> -vanillin
- Blog: Menthol Binding and Inhibition of α7-Nicotinic Acetylcholine Receptors
- Blog: Analysis of the interaction between human steroid 21-hydroxylase and various monoclonal antibodies using comparative structural modelling
- Blog: A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase
- Blog: Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target
- Blog: Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action
- Blog: Correction: A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination
- Blog: Inhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon Receptor
- Blog: GABA System in Anxiety Disorders: A Review of Current and Novel GABAergic Drugs
- Blog: Exploration of Piperidinols as Potential Antitubercular Agents
- Blog: Modeling of RAS complexes supports roles in cancer for less studied partners
- Blog: Identification of binding sites and favorable ligand binding moieties by virtual screening and self-organizing map analysis
- Blog: Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
- Blog: Communication Routes in ARID Domains between Distal Residues in Helix 5 and the DNA-Binding Loops
- Blog: Structural basis of antagonist selectivity in endothelin receptors
- Blog: Geissoschizine methyl ether, a corynanthean-type indole alkaloid from<i>Uncaria rhynchophylla</i>as a potential acetylcholinesterase inhibitor
- Blog: In cellulo crystallization of Trypanosoma brucei IMP dehydrogenase enables the identification of genuine co-factors
- Blog: C2230, a preferential use- and state-dependent CaV2.2 channel blocker, mitigates pain behaviors across multiple pain models
- Blog: AI approaches for the discovery and validation of drug targets
- Blog: Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
- Blog: Tricyclic antipsychotics and antidepressants can inhibit α5‐containing GABA<sub>A</sub> receptors by two distinct mechanisms
- Blog: Integrated Mass Spectrometry Reveals Celastrol As a Novel Catechol-O-methyltransferase Inhibitor
- Blog: Bioactive Profiling and Anti-Hyperglycemic Potential of Berberis nummularia Bunge: Role of Polyphenols and α-Amylase Inhibition
- Blog: Allosteric hotspots in the main protease of SARS-CoV-2
- Blog: A fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the L-arginine biosynthetic pathway of Mycobacterium tuberculosis
- Blog: Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS‐CoV‐2 Mpro for Next‐Generation PROTAC‐Based Therapeutics
- Blog: Candidate Binding Sites for Allosteric Inhibition of the SARS-CoV-2 Main Protease from the Analysis of Large-Scale Molecular Dynamics Simulations
- Blog: The function of GPCRs in different bone cells
- Blog: Selective Aurora A-TPX2 Interaction Inhibitors Have <i>In Vivo</i> Efficacy as Targeted Antimitotic Agents
- Blog: Isoliquiritigenin, a Chalcone Compound, Enhances Spontaneous Inhibitory Postsynaptic Response
- Blog: A non-canonical mechanism of GPCR activation
- Blog: Structural insights into lipid chain-length selectivity and allosteric regulation of FFA2
- Blog: Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study
- Blog: Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR
- Blog: Structural insights into inhibitor regulation of the DNA repair protein DNA-PKcs
History & citation
Current · Permanent link
- Precision Pharmacology through Allosteric Site Targeting merged into this direction (88% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_allosteric_site_targeting_fb059dd8,
title = {allosteric site targeting},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/allosteric-site-targeting/rdr_fb059dd82ec84a86a2d4c08472650364},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_allosteric_site_targeting_fb059dd8_v1,
title = {allosteric site targeting},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/allosteric-site-targeting/rdr_fb059dd82ec84a86a2d4c08472650364/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}